Price
Financials
Standalone, Rs crore| Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 17.33 | 22.66 | 26.75 | 29.19 |
| Expenses | 16.73 | 20.75 | 24.73 | 25.57 |
| Operating Profit | 0.60 | 1.91 | 2.02 | 3.62 |
| OPM % | 3.46% | 8.43% | 7.55% | 12.40% |
| Other Income | 0.05 | 0.08 | 0.83 | 0.22 |
| Interest | 0.14 | 0.03 | -0.01 | 0.03 |
| Depreciation | 1.16 | 1.40 | 1.56 | 1.19 |
| Profit before tax | -0.65 | 0.56 | 1.30 | 2.62 |
| Tax % | -0.00% | 25.00% | 23.08% | 38.17% |
| Net Profit | -0.65 | 0.42 | 1.00 | 1.61 |
| EPS in Rs | -0.39 | 0.25 | 0.61 | 0.98 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.54 | 1.82 | 3.42 | 17.09 | 27.23 | 46.03 | 88.74 |
| Expenses | 0.52 | 1.67 | 3.28 | 13.66 | 20.76 | 40.16 | 80.42 |
| Operating Profit | 0.02 | 0.15 | 0.14 | 3.43 | 6.47 | 5.87 | 8.32 |
| OPM % | 3.70% | 8.24% | 4.09% | 20.07% | 23.76% | 12.75% | 9.38% |
| Other Income | 0.01 | 0.01 | -0.01 | -0.00 | 0.28 | 1.53 | 1.55 |
| Interest | 0.04 | 0.03 | 0.02 | 0.07 | 0.09 | 0.11 | 0.16 |
| Depreciation | -0.00 | 0.01 | 0.11 | 0.78 | 0.53 | 2.46 | 5.07 |
| Profit before tax | -0.01 | 0.12 | -0.00 | 2.58 | 6.13 | 4.83 | 4.64 |
| Tax % | -0.00% | 25.00% | 7.75% | 28.06% | 24.64% | 27.37% | |
| Net Profit | -0.01 | 0.09 | -0.01 | 2.37 | 4.41 | 3.64 | 3.37 |
| EPS in Rs | -10.00 | 90.00 | -0.20 | 47.40 | 3.71 | 2.21 | 2.04 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 118% | 73% | 93% | ||
| Compounded Profit Growth | % | 99% | 6% | 24% | ||
| Stock Price CAGR | % | % | % | -35% | ||
| Return on Equity | % | 11% | 10% | 5% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.50 | 0.50 | 11.90 | 16.49 | 16.49 |
| Reserves | 0.07 | 0.01 | -0.00 | 2.03 | 3.12 | 37.00 | 40.37 |
| Borrowings | 0.40 | 0.69 | 2.54 | 2.48 | -0.00 | -0.00 | -0.00 |
| Other Liabilities | 0.30 | 0.42 | 1.60 | 3.25 | 5.94 | 14.79 | 15.81 |
| Total Liabilities | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 68.28 | 72.67 |
| Fixed Assets | 0.45 | 0.06 | 1.39 | 3.01 | 4.74 | 31.48 | 34.01 |
| CWIP | -0.00 | 0.45 | 1.90 | -0.00 | 0.86 | 0.61 | 0.53 |
| Investments | 0.24 | -0.00 | -0.00 | 2.00 | 6.51 | 18.58 | 11.81 |
| Other Assets | 0.09 | 0.62 | 1.35 | 3.25 | 8.85 | 17.61 | 26.32 |
| Total Assets | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 68.28 | 72.67 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.23 | 0.62 | 4.12 | 0.91 | 7.24 | 2.21 | |
| Cash from Investing Activity | -0.06 | -2.81 | -2.33 | -7.54 | -39.83 | -0.48 | |
| Cash from Financing Activity | 0.28 | 2.32 | -0.08 | 5.60 | 35.96 | -0.00 | |
| Net Cash Flow | 0.44 | 0.13 | 1.71 | -1.03 | 3.37 | 1.73 | |
| Free Cash Flow | 0.16 | -2.28 | 3.62 | -2.38 | -22.56 | -5.59 | |
| CFO/OP | 133% | 493% | 121% | 50% | 141% | 48% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | -0.00 | -0.00 | 20.28 | 0.85 | 2.01 | 25.61 | 24.84 |
| Inventory Days | 8.83 | 41.93 | 35.25 | 14.07 | 34.38 | 31.68 | |
| Days Payable | 94.19 | 113.45 | 69.03 | 75.17 | 107.32 | 92.84 | |
| Cash Conversion Cycle | -0.00 | -85.36 | -51.24 | -32.93 | -59.09 | -47.33 | -36.31 |
| Working Capital Days | -168.98 | -88.24 | -124.87 | -56.81 | -36.86 | -51.15 | -4.07 |
| ROCE % | 25.21% | 1.60% | 65.84% | 60.41% | 11.27% | 7.90% |
| Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 61.38% | 61.38% | 61.44% | 61.47% | 61.71% | 61.71% |
| FIIs | 3.92% | 4.06% | 3.50% | 3.47% | 0.73% | 0.96% |
| DIIs | 4.82% | 3.41% | 2.24% | 1.04% | 1.30% | 1.29% |
| Public | 29.87% | 31.14% | 32.82% | 34.02% | 36.27% | 36.03% |
| No. of Shareholders | 852 | 1,077 | 1,391 | 1,644 | 1,845 | 1,900 |
Fundamentals
Market Cap₹ 149 Cr.
Current Price₹ 90.6
Stock P/E29.5
Book Value₹ 34.5
ROCE7.90 %
ROE5.07 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)93%
Compounded Profit Growth (TTM)24%
Standalone figures.
Valuation
Market capRs 148 Cr
Enterprise valueRs 148 Cr
P/E (TTM)62.37x
Price to book58.42x
Price to sales8.65x
EV / EBITDA43.14x
EV / EBIT55.84x
EV / sales8.66x
Price to cash flow35.88x
Earnings yield1.60%
Profitability
Operating margin (excl. other income)20.07%
Operating margin (incl. other income)20.07%
EBITDA margin20.07%
Pre-tax margin15.10%
Net profit margin13.87%
ROE93.68%
ROCE52.89%
ROA36.74%
ROE, 3-year average136.84%
ROCE, 3-year average39.05%
ROA, 3-year average15.27%
ROIC (approx.)90.88%
Tax rate7.75%
Growth
Sales growth (latest year)399.71%
Sales CAGR, 3 years216.31%
Per share
EPS (TTM)Rs 1.44
EPS (latest year)Rs 47.40
EPS, 3-year averageRs 45.73
Book value per shareRs 1.53
Sales per shareRs 10.37
Cash flow per shareRs 2.50
Free cash flow per shareRs -3.39
Efficiency
Asset turnover2.07x
Fixed asset turnover5.68x
Inventory turnover11.21x
Inventory days33 days
Debtor days1 days
Debtors turnover427.25x
Creditor days93 days
Cash conversion cycle-36 days
Working capital days-4 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 2 Cr
Net debtRs 0 Cr
Debt to equity0.98x
Net debt / EBITDA0.05x
Interest coverage37.86x
Owners' fund to total sources30.63%
Debt to assets30.02%
Cash flow
Cash from Operating Activity (latest year)Rs 4 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 2 Cr
Free cash flow (latest year)Rs -6 Cr
FCFE (approx.: FCF + change in debt)Rs -6 Cr
Cash from ops / profit, 5 years1.10x
Sales to cash flow4.15x
Statement figures
Net sales (TTM)Rs 17 Cr
Net sales (latest year)Rs 17 Cr
Operating profit excl. other income (latest year)Rs 3 Cr
EBITDA (TTM)Rs 3 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 3 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 5 Cr
Total expenditure (latest year)Rs 14 Cr
Total income (latest year)Rs 17 Cr
Share capitalRs 0 Cr
ReservesRs 2 Cr
Shareholders' fundsRs 3 Cr
Total assetsRs 8 Cr
Net blockRs 3 Cr
InvestmentsRs 2 Cr
ReceivablesRs 0 Cr
InventoryRs 0 Cr
Other liabilitiesRs 3 Cr
Shares outstanding (crore)1.65
Ownership
Promoter holding61.71% (+0.33 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | NEPHROCARE | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -7.1% | -2.8% | -4.3 pts |
| 1 month | -11.0% | -6.8% | -4.2 pts |
| 3 months | +32.7% | -7.6% | +40.3 pts |
| 6 months | +73.2% | +0.4% | +72.8 pts |
| 1 year | -37.2% | -9.9% | -27.2 pts |
| 2 years | -65.7% | -13.6% | -52.1 pts |
Red flags
F-score 7 of 7No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
High low price variation greater than 100perc in previous 6 monthsHigh low price variation greater than 200perc in previous 365 DaysHigh low price variation greater than 75perc in previous 3 monthsLess than 100 unique PAN traded in previous 30 daysSME scrip is not regularly traded
Quick answers
What is the market cap of Nephro Care India Ltd?
Nephro Care India Ltd (NEPHROCARE) has a market capitalisation of Rs 149 Cr. at the 2026-10-01 close.
What is the P/E ratio of Nephro Care India Ltd?
Nephro Care India Ltd trades at a P/E of 29.5 on trailing twelve-month profit, at the 2026-10-01 close.
What is the 52-week high and low of Nephro Care India Ltd?
The 52-week high is Rs 156.35 and the 52-week low is Rs 50.05.